Cambridge Investment Research Advisors
DRTS icon

Cambridge Investment Research Advisors’s Alpha Tau Medical DRTS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179K Buy
+14,200
New +$129K ﹤0.01% 3595

Other funds holding DRTS

AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
FGG
Financial Guidance Group Palm Harbor, Florida $267M AUM 19.62% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $227M AUM 41.04% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
PWMG
Private Wealth Management Group Princeton, New Jersey $431M AUM 20.62% 1-Year Est. Return

Cambridge Investment Research Advisors's DRTS Position: Q2 2026 in Review

Cambridge Investment Research Advisors opened a new position in Alpha Tau Medical (DRTS) in Q2 2026: 14,200 shares worth $179K. The stake represents ﹤0.01% of the portfolio and ranks #3595 among its holdings.

13 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Cambridge Investment Research Advisors held 14,200 shares of Alpha Tau Medical worth $179K as of Q2 2026.
  • Alpha Tau Medical was a new Cambridge Investment Research Advisors position in Q2 2026.
  • Alpha Tau Medical made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3595 holding.
  • 13 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.